Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)
China flag China · Delayed Price · Currency is CNY
7.88
-0.34 (-4.14%)
Sep 10, 2026, 1:45 PM CST

SHA:600222 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
50.566050.5343.56-72.26
Depreciation & Amortization
61.1463.8564.9467.9362.9857.18
Other Amortization
9.499.288.387.774.953.31
Loss (Gain) From Sale of Assets
0.020.02-0.13-0.62-0.07-
Asset Writedown & Restructuring Costs
4.830.13-00.08-0.11.57
Loss (Gain) From Sale of Investments
1.12-1.24-10.676.4211.876.52
Provision & Write-off of Bad Debts
17.4817.487.0911.8633.8125.54
Other Operating Activities
68.3775.2657.1647.2265.1791.74
Change in Accounts Receivable
-223.14-218.71-91.32-3.07-380.27-130.93
Change in Inventory
-2.089.9491.06-7.38-70.61-37.3
Change in Accounts Payable
101.8823.22-196.56-123.27231.5782.8
Operating Cash Flow
98.8247.16-39.5943.74-124.4199.66
Operating Cash Flow Growth
-----35.72%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-19.47-21.12-37.23-43.13-66.62-39.07
Sale of Property, Plant & Equipment
0.020.070.170.220.190.06
Divestitures
0.090.09-1.80.20.57
Investment in Securities
8.06-17.6749.44-164137.25-87.67
Other Investing Activities
15.8538.85.8855.163.125.96
Investing Cash Flow
4.530.1618.25-150.02134.12-100.16

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-400----
Long-Term Debt Issued
-1,4811,3681,076950.091,298
Total Debt Issued
1,8141,8811,3681,076950.091,298
Long-Term Debt Repaid
--1,688-1,264-938.41-1,403-1,381
Lease Payments
-14.84-14.84-12.89-16.5-20.75-14.48
Net Debt Issued (Repaid)
219.12193.71103.77137.3-452.6-82.27
Issuance of Common Stock
41.2641.260.0634.46137.1795.16
Repurchase of Common Stock
-8.79-8.79-21.28-42.07-37.66-45.48
Common Dividends Paid
-58.19-50.76-69.07-50.17-63.51-84.56
Other Financing Activities
-303.43-190.78-23.26-52.97331.37-39.44
Financing Cash Flow
-110.03-15.37-9.7826.56-85.23-156.58

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-6.6831.95-31.11-79.72-75.51-157.08

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
79.3526.04-76.820.6-191.0360.58
Free Cash Flow Growth
-----7717.75%
Free Cash Flow Margin
4.58%1.48%-3.96%0.03%-9.74%3.78%
Free Cash Flow Per Share
0.140.05-0.140.00-0.340.11
Levered Free Cash Flow
178.5303.75-285.12-99.01361.28127.37
Unlevered Free Cash Flow
213.7338.95-247.84-65.03401.67179.77
Free Cash Flow After Leases
64.511.19-89.71-15.9-211.7846.1

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.111.111.60.83.734.54
Cash Income Tax Paid
80.1170.6559.0384.459.5351
Change in Working Capital
-114.19-177.63-216.88-140.48-230.82-92.2